Divis Laboratories Ltd vs Vivo Bio Tech Ltd

A side-by-side comparison of Divis Laboratories Ltd (DIVISLAB) and Vivo Bio Tech Ltd (VIVOBIOT) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divis Laboratories Ltd leads DIVISLAB vs VIVOBIOT on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

75.78
P/E ratio
5.54
11.59
P/B ratio
0.57
0.41%
Dividend yield
0.00%
₹96.73
EPS
₹4.24

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
-2.00%
22.00%
Return on capital
9.04%
33.00%
EBITDA margin
44.05%
24.32%
Net margin
15.60%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
0.70%
12.10%
Profit CAGR (3Y)
14.71%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.93L Cr
Market cap
₹52 Cr
₹10,560 Cr
Revenue
₹47 Cr
₹2,568 Cr
Net profit
₹7 Cr
0.00
Debt / equity
0.72
Divis Laboratories Ltd
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 11.5 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
Vivo Bio Tech Ltd
  • + ["Stock is trading at 0.56 times its book value"]
  • ["Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -4.81%", "The company has delivered a poor sales growth of 0.59% over past five years.", "Promoter holding is low: 30.6%", "Company has a low return on equity of 2.24% over last 3 years."]
Divis Laboratories Ltd full analysis Vivo Bio Tech Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.